Cargando…

HIV: how to manage low-level viraemia in people living with HIV

BACKGROUND: People living with HIV (PLWH) and receiving antiretroviral therapy (ART) have a goal of achieving and maintaining viral suppression; however, low-level viraemia (LLV) (HIV-RNA viral load levels of 50–999 copies/mL) persists in certain patients despite consistent medication adherence, lac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanners, Emily K, Benitez-Burke, Jessica, Badowski, Melissa E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903876/ https://www.ncbi.nlm.nih.gov/pubmed/35310296 http://dx.doi.org/10.7573/dic.2021-8-13

Ejemplares similares

Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study
por: Chun, Helen M, et al.
Publicado: (2022)

Low-level viraemia: An emerging concern among people living with HIV in Uganda and across sub-Saharan Africa
por: Nanyeenya, Nicholus, et al.
Publicado: (2022)

Low level viraemia and the risk of virological failure in HIV infected patients
por: Florea, Dragoş, et al.
Publicado: (2014)

Control of HIV viraemia is not enough in perinatal HIV
por: Foster, Caroline, et al.
Publicado: (2015)

The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review
por: Broyles, Laura N, et al.
Publicado: (2023)

The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda
por: Nanyeenya, Nicholus, et al.
Publicado: (2023)

Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study
por: Brattgård, Hanna, et al.
Publicado: (2022)

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia
por: Nightingale, Sam, et al.
Publicado: (2016)

Mobility during the post-partum period and viraemia in women living with HIV in South Africa
por: Odayar, Jasantha, et al.
Publicado: (2023)

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
por: Leierer, Gisela, et al.
Publicado: (2015)

Difference in factors associated with low-level viraemia and virological failure: results from the Austrian HIV Cohort Study
por: Leierer, Gisela, et al.
Publicado: (2014)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia
por: Viskovic, Klaudija, et al.
Publicado: (2014)

HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability
por: Ruelle, Jean, et al.
Publicado: (2012)

HIV-2 gene product-specific T cell responses and viraemia control
por: Leligdowicz, Aleksandra, et al.
Publicado: (2006)

Low-level viraemia despite emergence of dolutegravir-resistant variants
por: Botha, Johannes C., et al.
Publicado: (2022)

Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa
por: Myer, Landon, et al.
Publicado: (2015)

The Impact of Low-Level Viraemia on Virological Failure—Results From a Multicenter HIV Antiretroviral Therapy Cohort Study in Yunnan, China
por: An, Jing, et al.
Publicado: (2022)

Evidence Regarding Rapid Initiation of Antiretroviral Therapy in Patients Living with HIV
por: Michienzi, Sarah M., et al.
Publicado: (2021)

941. Incarcerated patients living with HIV: Atherosclerotic cardiovascular disease risk and management
por: Michienzi, Sarah M, et al.
Publicado: (2020)

CD8 encephalitis with CSF EBV viraemia and HIV drug resistance, a case series
por: Kerr, C., et al.
Publicado: (2020)

Patterns of detectable viraemia among children and adults with HIV infection taking antiretroviral therapy in Zimbabwe
por: Sovershaeva, Evgeniya, et al.
Publicado: (2019)

Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia
por: Saison, Julien, et al.
Publicado: (2014)

Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants
por: Garcia-Knight, Miguel A., et al.
Publicado: (2017)

Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy
por: Chastain, Daniel, et al.
Publicado: (2019)

939. Immunity to Hepatitis A and/or Hepatitis B Viruses Among Inmates Living with HIV
por: Poondi, Nivedha, et al.
Publicado: (2020)

Telemedicine for HIV Care: Current Status and Future Prospects
por: Smith, Erica, et al.
Publicado: (2021)

The Hidden Burden of Fractures in People Living With HIV
por: Premaor, Melissa O, et al.
Publicado: (2018)

A Systematic Review: Impact of SARS-CoV-2 Infection on Morbidity, Mortality, and Viral Suppression in Patients Living With HIV
por: Hanson, Hali A., et al.
Publicado: (2023)

Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study
por: Arenas-Pinto, Alejandro, et al.
Publicado: (2015)

Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection
por: Mhandire, Kudakwashe, et al.
Publicado: (2017)

HIV viraemia during pregnancy in women receiving preconception antiretroviral therapy in KwaDukuza, KwaZulu-Natal
por: Ntlantsana, Vuyokazi, et al.
Publicado: (2019)

Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment?
por: Januszka, Jenna E, et al.
Publicado: (2023)

Impact of low‐level viraemia on virological failure among Asian children with perinatally acquired HIV on first‐line combination antiretroviral treatment: a multicentre, retrospective cohort study
por: Sudjaritruk, Tavitiya, et al.
Publicado: (2020)

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
por: Murdock, Rachel M., et al.
Publicado: (2019)

Recovery of effective HIV-specific CD4(+) T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia
por: Adland, Emily, et al.
Publicado: (2018)

Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
por: Goldberg, Rachel N., et al.
Publicado: (2021)

Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
por: Dorward, Jienchi, et al.
Publicado: (2023)

New Antiretroviral Treatment for HIV
por: Badowski, Melissa E., et al.
Publicado: (2016)

Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS
por: Badowski, Melissa E, et al.
Publicado: (2016)

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
por: Atkinson, Andrew, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_le9fqsh6uj2mdhe61c0i3cifrm